We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Streptococcus Agalactiae?

By D. Jeffress
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Streptococcus agalactiae is a very common strain of bacteria that is completely harmless to most healthy people. Colonies of the bacteria can live within the digestive, reproductive, and urinary tracts without causing any negative health problems. In newborn babies and adults with weakened immune systems, however, Streptococcus agalactiae can become a source of severe, potentially life-threatening infections. The bacterium can cause serious damage to the lungs, brain, and heart if it is not recognized and treated right away. Intravenous (IV) antibiotics are usually effective at killing Streptococcus agalactiae colonies and promoting fast recovery.

Newborns are at an especially high risk of Streptococcus agalactiae infections because their immune systems are not yet strong enough to fight off pathogens. Pregnant mothers who carry the bacteria in their lower reproductive tracts can pass on infections to their babies as they are delivered. Cancer patients who receive immune system-suppressing chemotherapy and people who have chronic diseases such as HIV can also experience active infections.

The most common initial symptoms of a Streptococcus agalactiae infection in babies include fatigue, irritability, poor appetite, and fever. A persistent cough and shortness of breath may arise if the lungs and heart are involved. If the bacterium reaches the brain, it can cause seizures and set the stage for developmental disorders in the future. Adult patients may experience fevers, weakness, skin rashes, and urinary tract infections.

A simple blood test can confirm or rule out the presence of Streptococcus agalactiae in patients who exhibit symptoms. Physical exams and diagnostic imaging scans are useful in determining which organs are involved and to what extent. If a doctor suspects a brain infection, he or she may decide to collect a sample of fluid from the spinal cord to check in laboratory testing.

Most cases of Streptococcus agalactiae infection can be treated if they are discovered early. IV penicillin or similar antibiotics are able to stop the spread of infection and kill existing pathogens in the bloodstream. Newborns and adult patients may need to be hospitalized during treatment to ensure they receive sufficient fluids and supportive care for lingering symptoms. If the lungs, brain, or heart are involved, patients may require oxygen therapy and constant vital monitoring. Most patients who receive timely treatment are able to recover in less than one month.

Advancements in preventive medicine and testing techniques are helping to reduce the frequency of new Streptococcus agalactiae infections. Pregnant women are usually screened for bacterial colonies before they give birth. Antibiotics given before and during labor can lessen the chances of passing on an infection to an infant as well.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.